nodes	percent_of_prediction	percent_of_DWPC	metapath
Clomipramine—HTR2A—narcolepsy	0.744	1	CbGaD
Clomipramine—SLC6A2—locus ceruleus—narcolepsy	0.0144	0.14	CbGeAlD
Clomipramine—HTR2A—enteric nervous system—narcolepsy	0.0131	0.128	CbGeAlD
Clomipramine—HTR2A—locus ceruleus—narcolepsy	0.00866	0.0843	CbGeAlD
Clomipramine—SLC6A2—autonomic nervous system—narcolepsy	0.00766	0.0745	CbGeAlD
Clomipramine—HTR2A—pons—narcolepsy	0.00499	0.0486	CbGeAlD
Clomipramine—HTR2A—autonomic nervous system—narcolepsy	0.0046	0.0448	CbGeAlD
Clomipramine—HTR6—forebrain—narcolepsy	0.0037	0.036	CbGeAlD
Clomipramine—GSTP1—forebrain—narcolepsy	0.00244	0.0237	CbGeAlD
Clomipramine—HTR2C—brainstem—narcolepsy	0.00221	0.0216	CbGeAlD
Clomipramine—HTR2C—forebrain—narcolepsy	0.00214	0.0208	CbGeAlD
Clomipramine—SLC6A4—brainstem—narcolepsy	0.0021	0.0204	CbGeAlD
Clomipramine—SLC6A4—forebrain—narcolepsy	0.00203	0.0197	CbGeAlD
Clomipramine—HTR2B—forebrain—narcolepsy	0.00201	0.0195	CbGeAlD
Clomipramine—SLC6A2—brainstem—narcolepsy	0.00185	0.018	CbGeAlD
Clomipramine—SLC6A2—forebrain—narcolepsy	0.00178	0.0174	CbGeAlD
Clomipramine—GSTP1—medulla oblongata—narcolepsy	0.00176	0.0171	CbGeAlD
Clomipramine—GSTP1—midbrain—narcolepsy	0.00161	0.0156	CbGeAlD
Clomipramine—HTR2C—medulla oblongata—narcolepsy	0.00154	0.015	CbGeAlD
Clomipramine—HTR6—brain—narcolepsy	0.00153	0.0149	CbGeAlD
Clomipramine—HTR2C—midbrain—narcolepsy	0.00141	0.0137	CbGeAlD
Clomipramine—HRH2—brain—narcolepsy	0.0014	0.0137	CbGeAlD
Clomipramine—SLC6A4—midbrain—narcolepsy	0.00134	0.013	CbGeAlD
Clomipramine—SLC6A2—medulla oblongata—narcolepsy	0.00129	0.0125	CbGeAlD
Clomipramine—ADRA2A—forebrain—narcolepsy	0.00126	0.0123	CbGeAlD
Clomipramine—HTR2A—brainstem—narcolepsy	0.00111	0.0108	CbGeAlD
Clomipramine—HTR2A—forebrain—narcolepsy	0.00107	0.0104	CbGeAlD
Clomipramine—CYP2D6—brainstem—narcolepsy	0.00101	0.00985	CbGeAlD
Clomipramine—GSTP1—brain—narcolepsy	0.00101	0.00983	CbGeAlD
Clomipramine—CYP2D6—forebrain—narcolepsy	0.000977	0.00951	CbGeAlD
Clomipramine—ADRA2A—medulla oblongata—narcolepsy	0.000911	0.00887	CbGeAlD
Clomipramine—HTR2C—brain—narcolepsy	0.000887	0.00863	CbGeAlD
Clomipramine—ALB—brain—narcolepsy	0.000865	0.00842	CbGeAlD
Clomipramine—SLC6A4—brain—narcolepsy	0.000841	0.00818	CbGeAlD
Clomipramine—HTR2B—brain—narcolepsy	0.000833	0.00811	CbGeAlD
Clomipramine—ADRA2A—midbrain—narcolepsy	0.000833	0.0081	CbGeAlD
Clomipramine—HTR2A—medulla oblongata—narcolepsy	0.000775	0.00754	CbGeAlD
Clomipramine—SLC6A2—brain—narcolepsy	0.00074	0.0072	CbGeAlD
Clomipramine—Cyamemazine—HTR2A—narcolepsy	0.000714	0.109	CrCbGaD
Clomipramine—HTR2A—midbrain—narcolepsy	0.000708	0.00689	CbGeAlD
Clomipramine—ABCB1—forebrain—narcolepsy	0.000703	0.00684	CbGeAlD
Clomipramine—ADRA2A—brain—narcolepsy	0.000523	0.00509	CbGeAlD
Clomipramine—ABCB1—medulla oblongata—narcolepsy	0.000508	0.00494	CbGeAlD
Clomipramine—ABCB1—midbrain—narcolepsy	0.000464	0.00452	CbGeAlD
Clomipramine—Acepromazine—HTR2A—narcolepsy	0.000459	0.0699	CrCbGaD
Clomipramine—Thioproperazine—HTR2A—narcolepsy	0.000448	0.0683	CrCbGaD
Clomipramine—HTR2A—brain—narcolepsy	0.000445	0.00433	CbGeAlD
Clomipramine—Pipotiazine—HTR2A—narcolepsy	0.000441	0.0672	CrCbGaD
Clomipramine—CYP2D6—brain—narcolepsy	0.000405	0.00394	CbGeAlD
Clomipramine—Propiomazine—HTR2A—narcolepsy	0.000367	0.0558	CrCbGaD
Clomipramine—Chlorprothixene—HTR2A—narcolepsy	0.000347	0.0529	CrCbGaD
Clomipramine—Nortriptyline—HTR2A—narcolepsy	0.000341	0.0519	CrCbGaD
Clomipramine—Thioridazine—HTR2A—narcolepsy	0.000328	0.05	CrCbGaD
Clomipramine—Trimipramine—HTR2A—narcolepsy	0.000321	0.0489	CrCbGaD
Clomipramine—Methotrimeprazine—HTR2A—narcolepsy	0.000313	0.0478	CrCbGaD
Clomipramine—Promethazine—HTR2A—narcolepsy	0.000309	0.047	CrCbGaD
Clomipramine—Doxepin—HTR2A—narcolepsy	0.000306	0.0466	CrCbGaD
Clomipramine—Trifluoperazine—HTR2A—narcolepsy	0.000305	0.0464	CrCbGaD
Clomipramine—Perphenazine—HTR2A—narcolepsy	0.000301	0.0459	CrCbGaD
Clomipramine—ABCB1—brain—narcolepsy	0.000292	0.00284	CbGeAlD
Clomipramine—Desipramine—HTR2A—narcolepsy	0.00028	0.0427	CrCbGaD
Clomipramine—Promazine—HTR2A—narcolepsy	0.000272	0.0414	CrCbGaD
Clomipramine—Chlorpromazine—HTR2A—narcolepsy	0.000239	0.0364	CrCbGaD
Clomipramine—Imipramine—HTR2A—narcolepsy	0.000238	0.0362	CrCbGaD
Clomipramine—Amitriptyline—HTR2A—narcolepsy	0.000236	0.036	CrCbGaD
Clomipramine—HTR2A—GPCR ligand binding—HCRT—narcolepsy	0.000231	0.00157	CbGpPWpGaD
Clomipramine—ADRA2A—G alpha (i) signalling events—HRH3—narcolepsy	0.000231	0.00157	CbGpPWpGaD
Clomipramine—HTR2A—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00023	0.00156	CbGpPWpGaD
Clomipramine—ABCB1—Allograft Rejection—HLA-DQB1—narcolepsy	0.000228	0.00155	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—HCRTR1—narcolepsy	0.000227	0.00154	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—HCRTR2—narcolepsy	0.000227	0.00154	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—HCRTR2—narcolepsy	0.000226	0.00154	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—HCRTR1—narcolepsy	0.000226	0.00154	CbGpPWpGaD
Clomipramine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.000226	0.00153	CbGpPWpGaD
Clomipramine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.000226	0.00153	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—P2RY11—narcolepsy	0.000219	0.00149	CbGpPWpGaD
Clomipramine—HTR2B—GPCR ligand binding—HRH3—narcolepsy	0.000219	0.00149	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—P2RY11—narcolepsy	0.000218	0.00148	CbGpPWpGaD
Clomipramine—HTR2B—G alpha (q) signalling events—HTR2A—narcolepsy	0.000217	0.00147	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—PENK—narcolepsy	0.000216	0.00146	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—CPT1B—narcolepsy	0.000215	0.00146	CbGpPWpGaD
Clomipramine—ADRA2A—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.000214	0.00146	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR ligand binding—HCRT—narcolepsy	0.00021	0.00143	CbGpPWpGaD
Clomipramine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.000209	0.00142	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—HCRTR1—narcolepsy	0.000206	0.0014	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—HCRTR2—narcolepsy	0.000206	0.0014	CbGpPWpGaD
Clomipramine—HTR2A—GPCR ligand binding—PENK—narcolepsy	0.000206	0.0014	CbGpPWpGaD
Clomipramine—HRH2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000205	0.00139	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—HCRT—narcolepsy	0.000204	0.00139	CbGpPWpGaD
Clomipramine—HRH2—GPCR downstream signaling—TRH—narcolepsy	0.000202	0.00137	CbGpPWpGaD
Clomipramine—HTR2C—GPCR ligand binding—TRH—narcolepsy	0.000202	0.00137	CbGpPWpGaD
Clomipramine—HTR2A—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.000202	0.00137	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—P2RY11—narcolepsy	0.000199	0.00135	CbGpPWpGaD
Clomipramine—HTR6—GPCR ligand binding—TAC1—narcolepsy	0.000199	0.00135	CbGpPWpGaD
Clomipramine—HTR6—GPCR ligand binding—NPS—narcolepsy	0.000199	0.00135	CbGpPWpGaD
Clomipramine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.000194	0.00132	CbGpPWpGaD
Clomipramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000192	0.00131	CbGpPWpGaD
Clomipramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000192	0.00131	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR ligand binding—PENK—narcolepsy	0.000187	0.00127	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.000187	0.00127	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—HCRT—narcolepsy	0.000186	0.00127	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—HCRT—narcolepsy	0.000185	0.00126	CbGpPWpGaD
Clomipramine—HTR6—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000184	0.00125	CbGpPWpGaD
Clomipramine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.000184	0.00125	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—TRH—narcolepsy	0.000183	0.00125	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—HCRTR2—narcolepsy	0.000183	0.00124	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—HCRTR1—narcolepsy	0.000183	0.00124	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—PENK—narcolepsy	0.000182	0.00124	CbGpPWpGaD
Clomipramine—HTR2B—GPCR ligand binding—TAC1—narcolepsy	0.000182	0.00123	CbGpPWpGaD
Clomipramine—HTR2B—GPCR ligand binding—NPS—narcolepsy	0.000182	0.00123	CbGpPWpGaD
Clomipramine—HRH2—GPCR downstream signaling—HRH3—narcolepsy	0.000177	0.0012	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—P2RY11—narcolepsy	0.000177	0.0012	CbGpPWpGaD
Clomipramine—HTR2C—GPCR ligand binding—HRH3—narcolepsy	0.000177	0.0012	CbGpPWpGaD
Clomipramine—HTR2A—GPCR ligand binding—TRH—narcolepsy	0.000175	0.00119	CbGpPWpGaD
Clomipramine—HTR2C—G alpha (q) signalling events—HTR2A—narcolepsy	0.000175	0.00119	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—HCRTR2—narcolepsy	0.000174	0.00118	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—HCRTR1—narcolepsy	0.000174	0.00118	CbGpPWpGaD
Clomipramine—ABCB1—Allograft Rejection—HLA-DRB1—narcolepsy	0.000173	0.00118	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—HCRT—narcolepsy	0.000169	0.00115	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—P2RY11—narcolepsy	0.000168	0.00114	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.000168	0.00114	CbGpPWpGaD
Clomipramine—HTR2B—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000168	0.00114	CbGpPWpGaD
Clomipramine—HTR2A—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000167	0.00114	CbGpPWpGaD
Clomipramine—HTR2A—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000167	0.00114	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—HCRTR2—narcolepsy	0.000166	0.00113	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—HCRTR1—narcolepsy	0.000166	0.00113	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—PENK—narcolepsy	0.000166	0.00113	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—PENK—narcolepsy	0.000165	0.00112	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—HRH3—narcolepsy	0.000161	0.00109	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—P2RY11—narcolepsy	0.000161	0.00109	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR ligand binding—TRH—narcolepsy	0.000159	0.00108	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—HCRTR1—narcolepsy	0.000159	0.00108	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—HCRTR2—narcolepsy	0.000159	0.00108	CbGpPWpGaD
Clomipramine—HTR6—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000157	0.00107	CbGpPWpGaD
Clomipramine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.000156	0.00106	CbGpPWpGaD
Clomipramine—HRH2—GPCR ligand binding—HTR2A—narcolepsy	0.000156	0.00106	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—TRH—narcolepsy	0.000155	0.00105	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—P2RY11—narcolepsy	0.000154	0.00104	CbGpPWpGaD
Clomipramine—HTR2A—GPCR ligand binding—HRH3—narcolepsy	0.000154	0.00104	CbGpPWpGaD
Clomipramine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000152	0.00103	CbGpPWpGaD
Clomipramine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000152	0.00103	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—PENK—narcolepsy	0.000151	0.00103	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—HCRT—narcolepsy	0.00015	0.00102	CbGpPWpGaD
Clomipramine—HRH2—GPCR downstream signaling—TAC1—narcolepsy	0.000147	0.000997	CbGpPWpGaD
Clomipramine—HRH2—GPCR downstream signaling—NPS—narcolepsy	0.000147	0.000997	CbGpPWpGaD
Clomipramine—HTR2C—GPCR ligand binding—NPS—narcolepsy	0.000147	0.000996	CbGpPWpGaD
Clomipramine—HTR2C—GPCR ligand binding—TAC1—narcolepsy	0.000147	0.000996	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—HCRTR2—narcolepsy	0.000145	0.000983	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—HCRTR1—narcolepsy	0.000145	0.000983	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—HCRTR1—narcolepsy	0.000144	0.000982	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—HCRTR2—narcolepsy	0.000144	0.000982	CbGpPWpGaD
Clomipramine—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000144	0.000975	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—HCRT—narcolepsy	0.000143	0.000971	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—TRH—narcolepsy	0.000141	0.00096	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—TRH—narcolepsy	0.000141	0.000955	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—P2RY11—narcolepsy	0.00014	0.00095	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR ligand binding—HRH3—narcolepsy	0.00014	0.00095	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—P2RY11—narcolepsy	0.00014	0.000948	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—HCRT—narcolepsy	0.000137	0.000928	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—HRH3—narcolepsy	0.000136	0.000923	CbGpPWpGaD
Clomipramine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000135	0.000918	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—PENK—narcolepsy	0.000134	0.000911	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—HCRTR2—narcolepsy	0.000133	0.000907	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—HCRTR1—narcolepsy	0.000133	0.000907	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—TAC1—narcolepsy	0.000133	0.000905	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—NPS—narcolepsy	0.000133	0.000905	CbGpPWpGaD
Clomipramine—ALB—Vitamin B12 Metabolism—TNF—narcolepsy	0.000133	0.000901	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—HCRTR2—narcolepsy	0.000131	0.000893	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—HCRTR1—narcolepsy	0.000131	0.000893	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.000131	0.000888	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—HCRT—narcolepsy	0.000131	0.000888	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—P2RY11—narcolepsy	0.000129	0.000876	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—TRH—narcolepsy	0.000128	0.000872	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—PENK—narcolepsy	0.000127	0.000865	CbGpPWpGaD
Clomipramine—HTR2A—GPCR ligand binding—TAC1—narcolepsy	0.000127	0.000865	CbGpPWpGaD
Clomipramine—HTR2A—GPCR ligand binding—NPS—narcolepsy	0.000127	0.000865	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000127	0.000863	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—P2RY11—narcolepsy	0.000127	0.000863	CbGpPWpGaD
Clomipramine—SLC6A4—SIDS Susceptibility Pathways—TNF—narcolepsy	0.000125	0.000852	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—HRH3—narcolepsy	0.000124	0.000842	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—HRH3—narcolepsy	0.000123	0.000838	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—HCRTR2—narcolepsy	0.000122	0.000828	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—HCRTR1—narcolepsy	0.000122	0.000828	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—PENK—narcolepsy	0.000122	0.000827	CbGpPWpGaD
Clomipramine—HTR6—GPCR ligand binding—HTR2A—narcolepsy	0.00012	0.000814	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—HCRT—narcolepsy	0.000119	0.000808	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—HCRT—narcolepsy	0.000119	0.000806	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—P2RY11—narcolepsy	0.000118	0.000799	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—PENK—narcolepsy	0.000116	0.000791	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR ligand binding—NPS—narcolepsy	0.000116	0.000787	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR ligand binding—TAC1—narcolepsy	0.000116	0.000787	CbGpPWpGaD
Clomipramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000116	0.000787	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000114	0.000775	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—TRH—narcolepsy	0.000114	0.000775	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—HRH3—narcolepsy	0.000113	0.000765	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—TAC1—narcolepsy	0.000112	0.000764	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—NPS—narcolepsy	0.000112	0.000764	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—HCRT—narcolepsy	0.00011	0.000745	CbGpPWpGaD
Clomipramine—HTR2B—GPCR ligand binding—HTR2A—narcolepsy	0.000109	0.000743	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—TRH—narcolepsy	0.000108	0.000736	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—HCRT—narcolepsy	0.000108	0.000733	CbGpPWpGaD
Clomipramine—ALB—Folate Metabolism—TNF—narcolepsy	0.000108	0.000733	CbGpPWpGaD
Clomipramine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000107	0.000726	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—PENK—narcolepsy	0.000106	0.00072	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—PENK—narcolepsy	0.000106	0.000719	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—CHKB—narcolepsy	0.000105	0.000717	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—TRH—narcolepsy	0.000104	0.000704	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—NPS—narcolepsy	0.000103	0.000698	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—TAC1—narcolepsy	0.000103	0.000698	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—TAC1—narcolepsy	0.000102	0.000694	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—NPS—narcolepsy	0.000102	0.000694	CbGpPWpGaD
Clomipramine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—narcolepsy	0.000101	0.000684	CbGpPWpGaD
Clomipramine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—narcolepsy	0.000101	0.000684	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—HCRT—narcolepsy	0.0001	0.00068	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—HRH3—narcolepsy	0.0001	0.000679	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—TRH—narcolepsy	9.9e-05	0.000673	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—HCRTR2—narcolepsy	9.83e-05	0.000668	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—HCRTR1—narcolepsy	9.83e-05	0.000668	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—PENK—narcolepsy	9.77e-05	0.000664	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—PENK—narcolepsy	9.62e-05	0.000654	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—HRH3—narcolepsy	9.49e-05	0.000645	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—P2RY11—narcolepsy	9.49e-05	0.000645	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—NPS—narcolepsy	9.32e-05	0.000634	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—TAC1—narcolepsy	9.32e-05	0.000634	CbGpPWpGaD
Clomipramine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	9.15e-05	0.000622	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—HRH3—narcolepsy	9.08e-05	0.000617	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—TRH—narcolepsy	9.01e-05	0.000612	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—TRH—narcolepsy	8.99e-05	0.000611	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—PENK—narcolepsy	8.91e-05	0.000606	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	8.88e-05	0.000604	CbGpPWpGaD
Clomipramine—HRH2—GPCR downstream signaling—HTR2A—narcolepsy	8.82e-05	0.0006	CbGpPWpGaD
Clomipramine—HTR2C—GPCR ligand binding—HTR2A—narcolepsy	8.82e-05	0.000599	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—HRH3—narcolepsy	8.68e-05	0.00059	CbGpPWpGaD
Clomipramine—ALB—Selenium Micronutrient Network—TNF—narcolepsy	8.57e-05	0.000582	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—HCRTR2—narcolepsy	8.53e-05	0.00058	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—HCRTR1—narcolepsy	8.53e-05	0.00058	CbGpPWpGaD
Clomipramine—ALB—Metabolism—CHKB—narcolepsy	8.32e-05	0.000566	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—TRH—narcolepsy	8.3e-05	0.000564	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—TAC1—narcolepsy	8.28e-05	0.000563	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—NPS—narcolepsy	8.28e-05	0.000563	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—P2RY11—narcolepsy	8.24e-05	0.00056	CbGpPWpGaD
Clomipramine—ABCB1—Allograft Rejection—TNF—narcolepsy	8.18e-05	0.000556	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—TRH—narcolepsy	8.18e-05	0.000556	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—HCRT—narcolepsy	8.07e-05	0.000548	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—HTR2A—narcolepsy	8.01e-05	0.000544	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—HRH3—narcolepsy	7.9e-05	0.000537	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—HRH3—narcolepsy	7.88e-05	0.000536	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—TAC1—narcolepsy	7.87e-05	0.000535	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—NPS—narcolepsy	7.87e-05	0.000535	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—HCRTR1—narcolepsy	7.76e-05	0.000528	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—HCRTR2—narcolepsy	7.76e-05	0.000528	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—TRH—narcolepsy	7.58e-05	0.000515	CbGpPWpGaD
Clomipramine—HTR2A—SIDS Susceptibility Pathways—TNF—narcolepsy	7.55e-05	0.000513	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—TAC1—narcolepsy	7.52e-05	0.000511	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—NPS—narcolepsy	7.52e-05	0.000511	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—P2RY11—narcolepsy	7.5e-05	0.00051	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—CHKB—narcolepsy	7.47e-05	0.000508	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—CHKB—narcolepsy	7.29e-05	0.000496	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—HRH3—narcolepsy	7.28e-05	0.000495	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—TAC1—narcolepsy	7.19e-05	0.000489	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—NPS—narcolepsy	7.19e-05	0.000489	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—PENK—narcolepsy	7.19e-05	0.000489	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—HRH3—narcolepsy	7.17e-05	0.000487	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—CPT1B—narcolepsy	7.17e-05	0.000487	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—HCRT—narcolepsy	7.01e-05	0.000476	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR ligand binding—HTR2A—narcolepsy	6.97e-05	0.000473	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—CHKB—narcolepsy	6.87e-05	0.000467	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—HTR2A—narcolepsy	6.77e-05	0.00046	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—HRH3—narcolepsy	6.65e-05	0.000452	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—TAC1—narcolepsy	6.54e-05	0.000445	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—NPS—narcolepsy	6.54e-05	0.000445	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—TAC1—narcolepsy	6.53e-05	0.000444	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—NPS—narcolepsy	6.53e-05	0.000444	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—HCRT—narcolepsy	6.37e-05	0.000433	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—PENK—narcolepsy	6.25e-05	0.000424	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—HTR2A—narcolepsy	6.18e-05	0.00042	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—HTR2A—narcolepsy	6.14e-05	0.000418	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—TRH—narcolepsy	6.12e-05	0.000416	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—NPS—narcolepsy	6.03e-05	0.00041	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—TAC1—narcolepsy	6.03e-05	0.00041	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—TAC1—narcolepsy	5.94e-05	0.000404	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—NPS—narcolepsy	5.94e-05	0.000404	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—CHKB—narcolepsy	5.82e-05	0.000396	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—PENK—narcolepsy	5.68e-05	0.000386	CbGpPWpGaD
Clomipramine—ALB—Metabolism—CPT1B—narcolepsy	5.66e-05	0.000384	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—HTR2A—narcolepsy	5.61e-05	0.000381	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—NPS—narcolepsy	5.51e-05	0.000374	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—TAC1—narcolepsy	5.51e-05	0.000374	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—HRH3—narcolepsy	5.36e-05	0.000364	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—TRH—narcolepsy	5.31e-05	0.000361	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—CPT1B—narcolepsy	5.08e-05	0.000345	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—HTR2A—narcolepsy	4.98e-05	0.000339	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—CPT1B—narcolepsy	4.96e-05	0.000337	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—TRH—narcolepsy	4.83e-05	0.000328	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—HTR2A—narcolepsy	4.73e-05	0.000322	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—CPT1B—narcolepsy	4.67e-05	0.000317	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—HRH3—narcolepsy	4.66e-05	0.000316	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—HTR2A—narcolepsy	4.52e-05	0.000308	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CHKB—narcolepsy	4.49e-05	0.000305	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—TAC1—narcolepsy	4.44e-05	0.000302	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—NPS—narcolepsy	4.44e-05	0.000302	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—HRH3—narcolepsy	4.24e-05	0.000288	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	4.04e-05	0.000274	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—CPT1B—narcolepsy	3.96e-05	0.000269	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—HTR2A—narcolepsy	3.94e-05	0.000268	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—TAC1—narcolepsy	3.86e-05	0.000262	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—NPS—narcolepsy	3.86e-05	0.000262	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—HTR2A—narcolepsy	3.63e-05	0.000247	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—HTR2A—narcolepsy	3.57e-05	0.000243	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—TAC1—narcolepsy	3.51e-05	0.000239	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—NPS—narcolepsy	3.51e-05	0.000239	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—HTR2A—narcolepsy	3.31e-05	0.000225	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CPT1B—narcolepsy	3.05e-05	0.000208	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—HTR2A—narcolepsy	2.67e-05	0.000182	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—HTR2A—narcolepsy	2.11e-05	0.000144	CbGpPWpGaD
